Universitätsklinikum Göttingen

Nephroprotective treatment exemplified by Alport syndome (2019) Gross O, Rascher W Journal article Favorable radiation field decrease in gastric marginal zone lymphoma Experience of the German Study Group on Gastrointestinal Lymphoma (DSGL) (2019) Reinartz G, Pyra RP, Lenz G, Liersch R, Stueben G, Micke O, Willborn K, et al. Journal article Chemoradiotherapy plus induction versus consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-12 multicentre, open-label, randomised, phase 2 trial (2019) Fokas E, Allgaeuer M, Polat B, Klautke G, Grabenbauer G, Fietkau R, Kuhnt T, et al. Conference contribution Leukocytosis and Neutrophilia as independent prognostic Biomarkers for clinical Outcome in the randomized Phase III CAO/ARO/AIO-04 Rectal Cancer Study (2019) Diefenhardt M, Hofheinz RD, Martin D, Beissbarth T, Arnold D, Hartmann A, Von Der Grun J, et al. Conference contribution Brainstem biopsy in pediatric diffuse intrinsic pontine glioma in the era of precision medicine: the INFORM study experience (2019) Pfaff E, El Damaty A, Balasubramanian GP, Blattner-Johnson M, Worst BC, Stark S, Witt H, et al. Journal article Effect and safety of treatment with ACE-inhibitor Enalapril and β-blocker metoprolol on the onset of left ventricular dysfunction in Duchenne muscular dystrophy - A randomized, double-blind, placebo-controlled trial (2019) Dittrich S, Graf E, Trollmann R, Neudorf U, Schara U, Heilmann A, Von Der Hagen M, et al. Journal article European Surveillance System on Contact Allergies (ESSCA): Contact allergies in relation to body sites in patients with allergic contact dermatitis (2019) Oosterhaven JAF, Uter W, Aberer W, Armario-Hita JC, Ballmer-Weber BK, Bauer A, Czarnecka-Operacz M, et al. Journal article Chemo-RT plus induction or consolidation chemotherapy for rectal cancer: a randomised phase 2 trial (2019) Fokas E, Allgaeuer M, Polat B, Klautke G, Grabenbauer G, Fietkau R, Kuhnt T, et al. Conference contribution QoL after multimodal treatment of rectal cancer with/without oxaliplatin (phase 3, CAO/ARO/AIO-04) (2019) Kosmala R, Fokas E, Flentje M, Sauer R, Liersch T, Graeven U, Fietkau R, et al. Conference contribution Neutrophilia as prognostic factor for outcome in the CAO/ARO/ALO-04 phase 3 rectal cancer trial (2019) Diefenhardt M, Hofheinz R, Beissbarth T, Arnold D, Von Den Gruen JM, Liersch T, Stroebel P, et al. Conference contribution